Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DERL2 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of DERL2 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of DERL2 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DERL2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of DERL2 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | increases expression | ISO | Derl2 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of DERL2 mRNA | CTD | PMID:29097150 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DERL2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of DERL2 mRNA | CTD | PMID:17942748 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DERL2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of DERL2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DERL2 mRNA | CTD | PMID:19770486 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DERL2 mRNA | CTD | PMID:28628672 | all-trans-retinoic acid | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of DERL2 mRNA | CTD | PMID:33167477 | atrazine | decreases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of DERL2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of DERL2 mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of DERL2 mRNA | CTD | PMID:22228805 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of DERL2 mRNA | CTD | PMID:21932408 | bisphenol A | decreases expression | ISO | Derl2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of DERL2 mRNA | CTD | PMID:34947998 | bisphenol A | decreases methylation | ISO | DERL2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of DERL2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DERL2 mRNA | CTD | PMID:28628672 | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of DERL2 mRNA | CTD | PMID:26187450 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | copper(II) sulfate | decreases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of DERL2 mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of DERL2 mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of DERL2 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DERL2 mRNA | CTD | PMID:28628672 | dicrotophos | decreases expression | ISO | DERL2 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of DERL2 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DERL2 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | Derl2 (Rattus norvegicus) | 6480464 | Doxorubicin results in decreased expression of DERL2 mRNA | CTD | PMID:30261314 | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of DERL2 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DERL2 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of DERL2 mRNA | CTD | PMID:25629700 | indometacin | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DERL2 mRNA | CTD | PMID:28628672 | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of DERL2 mRNA | CTD | PMID:21823215 | ivermectin | decreases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of DERL2 protein | CTD | PMID:32959892 | L-serine | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Serine results in increased expression of DERL2 mRNA | CTD | PMID:29098664 | methidathion | decreases expression | EXP | | 6480464 | methidathion results in decreased expression of DERL2 mRNA | CTD | PMID:34813904 | methyl methanesulfonate | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of DERL2 mRNA | CTD | PMID:23649840 | p-toluidine | decreases expression | ISO | Derl2 (Rattus norvegicus) | 6480464 | 4-toluidine results in decreased expression of DERL2 mRNA | CTD | PMID:27638505 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of DERL2 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of DERL2 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of DERL2 mRNA | CTD | PMID:18445702 and PMID:23811191 | SB 431542 | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DERL2 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of DERL2 mRNA | CTD | PMID:19073995 | sodium arsenite | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of DERL2 mRNA | CTD | PMID:20886546 | sodium arsenite | affects expression | ISO | DERL2 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of DERL2 mRNA | CTD | PMID:34032870 | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of DERL2 mRNA | CTD | PMID:17555576 | thapsigargin | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of DERL2 mRNA | CTD | PMID:22378314 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of DERL2 mRNA | CTD | PMID:23409001 | triptonide | increases expression | EXP | | 6480464 | triptonide results in increased expression of DERL2 mRNA | CTD | PMID:33045310 | trovafloxacin | multiple interactions | EXP | | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of DERL2 mRNA | CTD | PMID:18930950 | tunicamycin | increases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of DERL2 mRNA | CTD | PMID:22378314 and PMID:29453283 | valproic acid | affects expression | ISO | DERL2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of DERL2 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | DERL2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of DERL2 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | DERL2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of DERL2 mRNA | CTD | PMID:27188386 | |